Press release
German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy
The company stated that it recently conducted a clinical study in the United States as part of its continued efforts to develop postbiotic-based ingredients using its proprietary co-fermentation technology. The research forms part of Koralo's wider initiative to explore applications of fermentation-derived compounds across multiple sectors.
Koralo is currently operating a manufacturing base in Jeonju, South Korea, where it is leveraging local fermentation infrastructure to support its production and development processes. The facility is expected to play a role in the company's planned expansion into international markets.
According to the company, its co-fermentation platform is being used to develop two product categories--one intended for human food applications and another for aquafeed. Both product lines are derived from a shared production approach, allowing for consistency across applications.
The company noted that its ingredients are designed for integration into a range of formats, including beverages, dairy products, baked goods, dietary supplements, and feed solutions. These developments are part of Koralo's broader focus on ingredient innovation within the food and feed industries.
Koralo indicated that it is currently targeting the United States and South Korea for its food-related initiatives, while also exploring opportunities in Europe and Southeast Asia for aquafeed applications.
The company stated that it will continue to focus on research and development of fermentation-based ingredients, with ongoing efforts directed toward expanding its presence in global markets.
Contact Details
Organization: Koralo GmbH (Koralo Co., Ltd.)
Contact Person: Sina Albanese (CEO)
Website: http://www.koralo-foods.com/
Email: Send Email [https://dashboard.kingnewswire.com/release-contact/44299]
Country: Korea South
Release Id: 27042644299
The post German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy appeared first on King Newswire. This content is provided by a third-party source. King Newswire is a press release distribution agency. We do not accept any responsibility or liability for the accuracy, content, images, videos, licences, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright concerns related to this article, please contact the company listed in the 'Media Contact' section above.
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. king Newswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact support@kingnewswire.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release German-Korean Biotech Startup Koralo Announces Clinical Research Update and Expansion Strategy here
News-ID: 4490566 • Views: …
More Releases from King Newswire
Genoscience Wins 2026 Global Award for High-Purity Research Peptides
Sarasota, Florida, United States, 27th Apr 2026 - Genoscience, a premier U.S. supplier of high-purity research peptides, announced it has received the 2026 Global Recognition Award. The company was honored for redefining institutional laboratory procurement through a secure supply chain built on domestic logistics, cGMP-compliant sourcing, and 99% analytical transparency.
Founded by Kristelle Dammarell, Genoscience entered a scientific supply market flooded with unverified importers. Historically, scientists sourcing Research Peptides in the…
VestaDAO Introduces Three Innovations to Break DeFi Liquidity Constraints
Protocol-Owned Markets, Contribution-Based Asset Ownership, Dual-Token Flywheel--VestaDAO Redefines Decentralized Finance
From the "liquidity mining" boom in 2020 to today's TVL stabilizing above $130 billion, DeFi has expanded rapidly--but it has also exposed deep structural flaws: protocols rely on high rewards to "rent" liquidity, only to collapse when capital exits; governance tokens lack value anchoring and devolve into speculative instruments; ordinary users' contributions cannot be properly recognized, leaving ecosystems dominated by whales.…
Digital Smart AI GPU Rental Platform Powers Scalable AI Solutions for Modern Ent …
As artificial intelligence becomes a central driver of productivity and innovation, businesses are under increasing pressure to adopt AI capabilities quickly and cost-effectively. Digital Smart AI is addressing this demand by offering a scalable AI solutions ecosystem combined with a flexible GPU rental platform, allowing companies to access high-performance computing without the burden of traditional infrastructure investment.
Unlike conventional AI deployment models that require heavy upfront spending on hardware and maintenance,…
Valyra Exchange: A Comprehensive Platform Powering the Future of Digital Finance
United States, 27th Apr 2026 - As the global financial system shifts toward decentralization, platforms that can bridge traditional finance and blockchain technology are gaining increasing attention. Valyra Exchange is one such platform, positioning itself as a full-stack digital asset ecosystem that goes beyond simple trading and moves toward a more integrated financial infrastructure.
Unlike conventional crypto exchanges that focus primarily on buying and selling assets, Valyra Exchange is structured to…
